2nd Quarter - Report
ENDGAME STRATEGIES, LLC for MCGOVERN & ASSOCIATES
Client
Income
$15,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Issues relating to drug innovation, drug repurposing, intellectual property protections for innovators, and the Hatch-Waxman Act. The Independent Innovator and Repurposing Act, HR 4287; S 2150
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN DUFFIELD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.